AFAP1 and pancreatic neoplasm: A recent study has shown that treatment with oridonin (95 μM) and/or knockdown of lncRNAs AFAP1-AS1 for 24 h inhibited cell invasion capacity of PANC-1 and BxPC-3 pancreatic cancer cell lines as assessed by transwell migration assay.